Status:
WITHDRAWN
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
Lead Sponsor:
University of Colorado, Denver
Conditions:
Open Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
40-89 years
Brief Summary
This study is designed with the intention to further elucidate the effects of omega-3 fatty acids on intraocular pressure (IOP) and signs/symptoms of dry eye. Prior studies have shown statistically si...
Detailed Description
The purpose of this research project is to determine the effects of omega-3 fatty acid supplementation on intraocular pressure (IOP) as well as the signs and symptoms of dry eye. We hypothesize that d...
Eligibility Criteria
Inclusion
- Diagnosis of Ocular Hypertension or Open Angle Glaucoma of mild to moderate severity, with or without previously diagnosed dry eye syndrome, who are currently on monotherapy with a prostaglandin analog.
- Age 40-89 of either gender, of any race/ethnicity
Exclusion
- Females who are currently pregnant or planning to become pregnant during the study period
- Age \<40 years old
- Diagnosis of any other form of glaucoma other than open-angle
- Patients with known hypersensitivity (i.e., anaphylactic reaction) to omega-3 fatty acids or any of its components
- Patients with cirrhosis or with known liver disease
- Patients with diagnosed celiac disease
- Patients with a hypersensitivity to fish or shellfish
- Patients with paroxysmal or persistent atrial fibrillation
- Patients who are currently using medical or recreational marijuana
- Patients currently on any anticoagulation therapy including warfarin, dabigatran, apixaban, rivaroxaban, clopidogrel, cilostazol, dipyridamole, prasugrel, ticlopidine, ticagrelor
- Patients currently on Lovaza, an omega- 3 fatty acid supplement requiring a prescription
- Patients with any recent ocular surgery or laser treatment within 3 months
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02295358
Start Date
November 1 2014
End Date
November 1 2015
Last Update
July 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Eye Center
Aurora, Colorado, United States, 80045